Publication Name	World Journal of Hepatology
Manuscript ID	13610
Country	China

Received	2014-08-28 08:17
Peer-Review Started	2014-08-29 08:24
To Make the First Decision	2014-10-14 18:09
Return for Revision	2014-10-20 17:40
Revised	2014-11-10 14:26
Second Decision	2015-01-29 09:18
Accepted by Journal Editor-in-Chief	2015-01-29 16:42
Accepted by Executive Editor-in-Chief	2015-02-09 10:40
Articles in Press	2015-02-09 10:40
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-02-11 23:42
Typeset the Manuscript	2015-04-21 13:58
Publish the Manuscript Online	2015-05-13 10:06

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Review
Article Title	Immunotherapy for hepatocellular carcinoma: From basic research to clinical use
Manuscript Source	Invited Manuscript
All Author List	Yu-Peng Hong, Zi-Duo Li, Pankaj Prasoon and Qi Zhang
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81401954
Corresponding Author	Qi Zhang, MD, Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou 310009, Zhejiang Province, China. zhangqi86@gmail.com
Key Words	Interferon; Chemokine; Tumor vaccine; Adoptive immunotherapy; Chimeric antigen receptor; Checkpoint blockade
Core Tip	This paper supplies a comprehensive review of immunotherapy for hepatocellular carcinoma from basic experiments to clinical trials. The development of interferon, chemokines, tumor vaccines, adoptive immunotherapy, including natural killer, natural killer T and T cells armed with chimeric antigen receptor, as well as regulatory T cell is summarized.
Publish Date	2015-05-13 10:06
Citation	Hong YP, Li ZD, Prasoon P, Zhang Q. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol 2015; 7(7): 980-992
URL	http://www.wjgnet.com/1948-5182/full/v7/i7/980.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i7.980

Full Article (PDF)	WJH-7-980.pdf
Full Article (Word)	WJH-7-980.doc
Manuscript File	13610-Review.docx
Answering Reviewers	13610-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13610-Conflict-of-interest statement.pdf
Copyright License Agreement	13610-Copyright assignment.pdf
Peer-review Report	13610-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	13610-Journal Editor-in-Chief's Review Report.pdf
Scientific Misconduct Check	13610-Scientific misconduct check.pdf
Scientific Editor Work List	13610-Scientific editor work list.pdf